Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov;23(6):871-883.
doi: 10.1007/s10741-018-9711-2.

Left ventricular restoration devices post myocardial infarction

Tom Hendriks  1 , Remco A J Schurer  1 , Lawien Al Ali  1 , Ad F M van den Heuvel  1 , Pim van der Harst  2
Affiliations
Review

Left ventricular restoration devices post myocardial infarction

Tom Hendriks et al. Heart Fail Rev. 2018 Nov.

Abstract

Even in the era of percutaneous reperfusion therapy, left ventricular (LV) remodeling after myocardial infarction (MI) leading to heart failure remains a major health concern. Contractile dysfunction of the infarcted myocardium results in an increased pressure load, leading to maladaptive reshaping of the LV. Several percutaneous transcatheter procedures have been developed to deliver devices that restore LV shape and function. The purposes of this review are to discuss the spectrum of transcatheter devices that are available or in development for attenuation of adverse LV remodeling and to critically examine the available evidence for improvement of functional status and cardiovascular outcomes.

Keywords: Left ventricular remodeling; Left ventricular restoration; Myocardial infarction; Transcatheter devices.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Figures

Fig. 1
Fig. 1
An overview of the discussed transcatheter left ventricular restoration devices, grouped by indication for use based on the stage of adverse left ventricular remodeling post myocardial infarction. The represented transvenous annuloplasty device is the mitral loop cerclage, the other devices are differently shaped
See this image and copyright information in PMC

References

    1. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000;35:569–582. doi: 10.1016/S0735-1097(99)00630-0. - DOI - PubMed
    1. Bhatt AS, Ambrosy AP, Velazquez EJ. Adverse remodeling and reverse remodeling after myocardial infarction. Curr Cardiol Rep. 2017;19:71. doi: 10.1007/s11886-017-0876-4. - DOI - PubMed
    1. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44–51. doi: 10.1161/01.CIR.76.1.44. - DOI - PubMed
    1. Solomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK, Warnica JW, Khrakovskaya M, Arnold JM, Schwartz Y, Velazquez EJ, Califf RM, McMurray J, Pfeffer MA. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation. 2005;111:3411–3419. doi: 10.1161/CIRCULATIONAHA.104.508093. - DOI - PubMed
    1. Bolognese L, Neskovic AN, Parodi G, Cerisano G, Buonamici P, Santoro GM, Antoniucci D. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation. 2002;106:2351–2357. doi: 10.1161/01.CIR.0000036014.90197.FA. - DOI - PubMed

MeSH terms